Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Convulsions are clinical symptoms defined by sudden, involuntary, and paroxysmal contractions of the skeletal muscles, often resulting from abnormal and excessive electrical activity in the brain [1][2]. While the term is frequently used synonymously with 'seizures,' convulsions specifically denote the motoric phase of a seizure event, which can be tonic, clonic, or tonic-clonic in nature [1]. Because convulsions represent a physiological state or clinical phenotype rather than a specific protein or molecular entity, they are not considered a therapeutic target in the traditional pharmacological sense; instead, they serve as the clinical indication for anti-epileptic drugs (AEDs) [3]. These drugs act on various molecular targets, such as the Gamma-aminobutyric acid (GABA) system or voltage-gated ion channels, to restore the balance between excitatory and inhibitory neurotransmission [4]. Etiologies for convulsions are diverse, ranging from chronic conditions like epilepsy to acute triggers such as high fever, metabolic imbalances, or neurovascular insults [2]. Citations: [1] StatPearls: Seizure (https://www.ncbi.nlm.nih.gov/books/NBK430765/); [2] Mayo Clinic: Seizures (https://www.mayoclinic.org/diseases-conditions/seizure/symptoms-causes/syc-20365711); [3] Epilepsy Foundation: What is a Seizure? (https://www.epilepsy.com/what-is-epilepsy/understanding-seizures); [4] NIH: Epilepsy and Seizures (https://www.ninds.nih.gov/health-information/disorders/epilepsy-and-seizures).
Convulsions are clinical manifestations rather than molecular targets; however, medications treat them by modulating targets such as GABA-A receptors (potentiation), voltage-gated sodium channels (blockade), or SV2A proteins (binding) to stabilize neuronal membranes and inhibit excessive firing [1][3].
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Convulsions.